Form4insider filings, from the source

SEC Form 4 · accession 0000905148-16-002140

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
R Kent McGaughy Jr.
Director · 10% Owner
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A common stockF1,F5,F6Dec 16, 2016P164,753$22.9909A1,916,642ISee footnote
Class A common stockF2,F6holding———4,591IBy Lagos Trust
Class A common stockF3,F6holding———280IBy Traweek Children's Trust
Class A common stockF4,F6holding———2,739ISee footnote
Class A common stockholding———25,004D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses